• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Sustained humoral response 6 months after the anti-SARS-CoV-2 mRNA-BNT162b2 vaccine in haemodialysis patients: should booster vaccine doses be given to all patients at the same time?血液透析患者接种抗SARS-CoV-2 mRNA-BNT162b2疫苗6个月后的持续体液反应：是否应同时为所有患者接种加强针？
Clin Kidney J. 2022 Feb 16;15(5):1012-1014. doi: 10.1093/ckj/sfac047. eCollection 2022 May.
2
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies.智利科兴疫苗和加强针的血清学研究：抗 SARS-CoV-2 刺突抗体的免疫原性和持久性。
BMC Med. 2022 Jun 9;20(1):216. doi: 10.1186/s12916-022-02406-0.
3
Demographic and Clinical Factors Associated With Anti-SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine Doses.接种 2 剂 BNT162b2 mRNA 疫苗后与抗 SARS-CoV-2 抗体水平相关的人口统计学和临床因素。
JAMA Netw Open. 2022 May 2;5(5):e2212996. doi: 10.1001/jamanetworkopen.2022.12996.
4
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.维持性血液透析患者对辉瑞 BNT162b2 疫苗加强针的体液反应。
Am J Nephrol. 2022;53(2-3):207-214. doi: 10.1159/000521676. Epub 2022 Feb 16.
5
Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.日本肾移植受者接种第二剂SARS-CoV-2 mRNA疫苗后的长期体液免疫反应
Front Microbiol. 2022 Jun 9;13:922042. doi: 10.3389/fmicb.2022.922042. eCollection 2022.
6
Humoral immune response after different SARS-CoV-2 vaccination regimens.不同 SARS-CoV-2 疫苗接种方案后的体液免疫应答。
BMC Med. 2022 Jan 21;20(1):31. doi: 10.1186/s12916-021-02231-x.
7
Persistence of Immune Response in Health Care Workers After Two Doses BNT162b2 in a Longitudinal Observational Study.在一项纵向观察研究中，BNT162b2 两剂接种后医护人员的免疫反应持续存在。
Front Immunol. 2022 Mar 4;13:839922. doi: 10.3389/fimmu.2022.839922. eCollection 2022.
8
Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals.在未感染和既往感染个体中，接受 BNT162b2 疫苗第一、第二和第三剂后，针对 SARS-CoV-2 的特异性抗体反应的差异：一项在医护人员中进行的为期 1 年的观察性研究。
Front Immunol. 2022 May 27;13:876533. doi: 10.3389/fimmu.2022.876533. eCollection 2022.
9
Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components.辉瑞/生物科技基于 mRNA 的 BNT162b2 疫苗加强剂接种后针对 SARS-CoV-2 的特异性体液和细胞免疫应答：适应性免疫系统成分的综合研究。
Front Immunol. 2022 Mar 24;13:856657. doi: 10.3389/fimmu.2022.856657. eCollection 2022.
10
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.维持性血液透析或腹膜透析患者接种第三剂 BNT162b2 疫苗后的 SARS-CoV-2 抗体反应。
Am J Kidney Dis. 2022 Feb;79(2):185-192.e1. doi: 10.1053/j.ajkd.2021.08.005. Epub 2021 Sep 8.

本文引用的文献

1
Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost.血液透析患者接种mRNA-BNT162b2疫苗6个月后体液免疫反应减弱：是时候加强接种了。
Kidney Int. 2021 Dec;100(6):1334-1335. doi: 10.1016/j.kint.2021.10.006. Epub 2021 Oct 14.
2
Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.血液透析患者对 SARS-CoV-2 mRNA 疫苗的体液和细胞免疫应答的预测因素和动力学：一项多中心观察性研究。
J Am Soc Nephrol. 2021 Dec 1;32(12):3208-3220. doi: 10.1681/ASN.2021070908.
3
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis.血液透析患者中 SARS-CoV-2 mRNA 疫苗的细胞和体液免疫原性。
EBioMedicine. 2021 Aug;70:103524. doi: 10.1016/j.ebiom.2021.103524. Epub 2021 Aug 12.
4
Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.慢性肾脏病患者对SARS-CoV-2疫苗接种的早期免疫反应综述
Kidney Int Rep. 2021 Sep;6(9):2292-2304. doi: 10.1016/j.ekir.2021.06.027. Epub 2021 Jul 6.
5
The humoral immune response to SARS-CoV-2 mounts and is durable in symptomatic haemodialysis patients.有症状的血液透析患者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的体液免疫反应增强且持久。
Nephrol Dial Transplant. 2021 May 27;36(6):1132-1134. doi: 10.1093/ndt/gfab047.

Sustained humoral response 6 months after the anti-SARS-CoV-2 mRNA-BNT162b2 vaccine in haemodialysis patients: should booster vaccine doses be given to all patients at the same time?

作者信息

La Milia Vincenzo, Tonolo Silvia, Luzzaro Francesco, Bonato Claudio, Limardo Monica, Longhi Selena, Ravasi Chiara, Viganò Sara, Cavalli Andrea

机构信息

Nephrology and Dialysis Unit, A. Manzoni Hospital, Lecco, Italy.

Microbiology Unit, A. Manzoni Hospital, Lecco, Italy.

出版信息

Clin Kidney J. 2022 Feb 16;15(5):1012-1014. doi: 10.1093/ckj/sfac047. eCollection 2022 May.

DOI:10.1093/ckj/sfac047
PMID:35498885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9050530/
Abstract
摘要